Revolution Medicines Inc (RVMD) — Quality & forensics

As of 2026-09-03 — refreshed nightly. Closelook readings from an investment research diary, not ratings or advice.

The Closelook module scores

31 /100 composite · 6 modules · general weight set

Quality 1
Growth 10
Balance sheet 64
Cash quality 42
Capital allocation 7
Momentum 93

Scores are computed nightly across the coverage universe and read relative to it — the methodology lives in the company-scoring explainer.

Financial forensics — the academic screens

34.75 Altman Z-Score

Sits in the safe zone (above 2.99). The Z-Score estimates financial-distress risk from five balance-sheet and earnings ratios.

1/7 Piotroski F-Score

Nine binary fundamental-strength checks across profitability, leverage and operating efficiency.

Continue: the RVMD chart & overview

FAQ · from the current data · as of 2026-09-03

Quick answers

What is Revolution Medicines Inc's Closelook quality reading?

The composite reads 31/100 across 6 modules, as of 2026-09-03: quality 1, growth 10, balance sheet 64, cash quality 42, capital allocation 7, momentum 93. Closelook scores are research diary readings, not ratings or investment advice.

What is Revolution Medicines Inc's Altman Z-Score?

34.75, which sits in the safe zone (above 2.99) as of 2026-09-03. The Altman Z-Score estimates financial distress risk from five balance-sheet and earnings ratios.

What is Revolution Medicines Inc's Piotroski F-Score?

1 of 7, as of 2026-09-03. The F-Score counts nine binary fundamental-strength signals across profitability, leverage and operating efficiency.